These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1981556)

  • 1. Selective alpha 2-adrenoceptor blockade does not enhance glucose-evoked insulin release.
    John GW; Doxey JC; Walter DS; Reid JL
    Eur J Pharmacol; 1990 Oct; 187(3):531-6. PubMed ID: 1981556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of alpha- and beta-adrenoceptor subtypes in mediating the effects of catecholamines on fasting glucose and insulin concentrations in the rat.
    John GW; Doxey JC; Walter DS; Reid JL
    Br J Pharmacol; 1990 Aug; 100(4):699-704. PubMed ID: 1976400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity profile of the alpha 2-adrenoceptor antagonist efaroxan in relation to plasma glucose and insulin levels in the rat.
    Berridge TL; Doxey JC; Roach AG; Smith CF
    Eur J Pharmacol; 1992 Mar; 213(2):205-12. PubMed ID: 1355733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-adrenoceptors and insulin release from pancreatic islets of normal and diabetic rats.
    Ostenson CG; Cattaneo AG; Doxey JC; Efendic S
    Am J Physiol; 1989 Sep; 257(3 Pt 1):E439-43. PubMed ID: 2571300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of alpha-2 adrenergic receptor subtype involved in the release of insulin from isolated rat pancreatic islets.
    Niddam R; Angel I; Bidet S; Langer SZ
    J Pharmacol Exp Ther; 1990 Sep; 254(3):883-7. PubMed ID: 1975625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of beta 2-adrenoceptor-mediated mechanisms in the cardiovascular responses to alpha 1- and alpha 2-adrenoceptor antagonism in conscious, unrestrained, Long Evans and Brattleboro rats.
    Gardiner SM; Bennett T
    Br J Pharmacol; 1988 Jan; 93(1):9-22. PubMed ID: 2894880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of alpha-adrenoceptors in the regulation of renal tubular sodium reabsorption and renin secretion in the rabbit.
    Hesse IF; Johns EJ
    Br J Pharmacol; 1985 Mar; 84(3):715-24. PubMed ID: 2859065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo pharmacological profile of SL 84.0418, a new selective, peripherally active alpha 2-adrenoceptor antagonist.
    Angel I; Grosset A; Perrault G; Schoemaker H; Langer SZ
    Eur J Pharmacol; 1993 Apr; 234(2-3):137-45. PubMed ID: 8097719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of alpha-2-adrenoceptors results in an increase in F-actin formation in HIT-T15 pancreatic B-cells.
    Cable HC; el-Mansoury A; Morgan NG
    Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):169-74. PubMed ID: 7717971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic alpha 2-adrenoceptor blockade on platelet and lymphocyte adrenoceptor binding in normal volunteers.
    Glue P; Payvandi N; Kay G; Elliott JM; Nutt DJ
    Life Sci; 1991; 49(8):PL21-5. PubMed ID: 1678132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 2-adrenoceptor blockade does not enhance glucose-induced insulin release in normal subjects or patients with noninsulin-dependent diabetes.
    Ostenson CG; Pigon J; Doxey JC; Efendic S
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1054-9. PubMed ID: 2903169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of desipramine on stimulation-induced contractions of the vas deferens of rats pretreated either chronically with desipramine or acutely with idazoxan.
    Doxey JC; Roach AG; Samuel J
    Clin Sci (Lond); 1985; 68 Suppl 10():155s-159s. PubMed ID: 2857613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective alpha 2 receptor blockade facilitates the insulin response to adrenaline but not to glucose in man.
    Struthers AD; Brown DC; Brown MJ; Schumer B; Bloom SR
    Clin Endocrinol (Oxf); 1985 Nov; 23(5):539-46. PubMed ID: 3002669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal responses to noradrenaline in the cerebral cortex: evidence against the involvement of alpha 2-adrenoceptors.
    Bradshaw CM; Sheridan RD; Szabadi E
    Br J Pharmacol; 1984 Jun; 82(2):453-8. PubMed ID: 6145471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The insulin-secreting cell line, RINm5F, expresses an alpha-2D adrenoceptor and nonadrenergic idazoxan-binding sites.
    Remaury A; Paris H
    J Pharmacol Exp Ther; 1992 Jan; 260(1):417-26. PubMed ID: 1346166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the alpha-adrenoceptors mediating positive inotropy of rat left atria by use of selective agonists and antagonists.
    Williamson KL; Broadley KJ
    Arch Int Pharmacodyn Ther; 1987 Feb; 285(2):181-98. PubMed ID: 2883945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of alpha-2 adrenergic receptor subtypes in hyperglycemia.
    Angel I; Niddam R; Langer SZ
    J Pharmacol Exp Ther; 1990 Sep; 254(3):877-82. PubMed ID: 1975624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative stimulus effects of the alpha 2-adrenoceptor antagonist idazoxan.
    Sanger DJ
    Psychopharmacology (Berl); 1989; 99(1):117-21. PubMed ID: 2571173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the actions of noradrenaline and UK-14,304 in the longitudinal smooth muscle of the rat isolated portal vein--no evidence for a population of post-junctional alpha 2-adrenoceptors.
    Downing OA; Stein W; Wilson KA; Wilson VG
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):239-45. PubMed ID: 2848204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alpha adrenoceptor antagonist properties of idazoxan in normal subjects.
    Elliott HL; Jones CR; Vincent J; Lawrie CB; Reid JL
    Clin Pharmacol Ther; 1984 Aug; 36(2):190-6. PubMed ID: 6146423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.